Selected article for: "analytical study and study period"

Author: Luo, Cheng-Xin; Wen, Zhong-Hui; Zhen, Yu; Wang, Zhu-Jun; Mu, Jing-Xi; Zhu, Min; Ouyang, Qin; Zhang, Hu
Title: Chinese research into severe ulcerative colitis has increased in quantity and complexity
  • Document date: 2018_3_16
  • ID: jmjtr1pb_46
    Snippet: There were 201 publications regarding SUC published in Chinese medical journals between 2001 and 2015. The number of publications increased rapidly. Significant increase was found in analytical studies and clinical trials over the study period, with research into the management of SUC, included pharmacotherapy, nutrition support as well as surgery, predominating. About 46.2% of the observational analytical studies and clinical trials focused on T.....
    Document: There were 201 publications regarding SUC published in Chinese medical journals between 2001 and 2015. The number of publications increased rapidly. Significant increase was found in analytical studies and clinical trials over the study period, with research into the management of SUC, included pharmacotherapy, nutrition support as well as surgery, predominating. About 46.2% of the observational analytical studies and clinical trials focused on Traditional Chinese Medicine, with little research on the efficacy of cyclosporin and infliximab in the disease management. About 6222 SUC patients were reported in 201 relevant papers (ratio of male/female patients: 1.38). The number of patients reported in each 5-year period significantly increased. The colectomy rate and short-term mortality rate were 7.7% and 0.8% respectively. Total proctocolectomy with ileal pouch-anal anastomosis was the most commonly employed operation.

    Search related documents:
    Co phrase search for related documents
    • infliximab cyclosporin and mortality rate: 1, 2, 3
    • infliximab cyclosporin and nutrition support: 1, 2
    • infliximab cyclosporin and pharmacotherapy nutrition support: 1, 2
    • infliximab cyclosporin and pouch anal anastomosis: 1, 2
    • infliximab cyclosporin and short term: 1, 2
    • infliximab cyclosporin and short term mortality rate: 1, 2
    • infliximab cyclosporin and short term mortality rate colectomy rate: 1, 2
    • infliximab cyclosporin and significant increase: 1
    • infliximab cyclosporin and study period: 1, 2
    • infliximab cyclosporin and SUC management: 1, 2, 3
    • infliximab cyclosporin and SUC management research: 1, 2
    • infliximab cyclosporin and surgery pharmacotherapy nutrition support: 1, 2
    • infliximab cyclosporin and total proctocolectomy: 1, 2
    • infliximab cyclosporin efficacy and little research: 1, 2
    • infliximab cyclosporin efficacy and mortality rate: 1, 2
    • infliximab cyclosporin efficacy and nutrition support: 1, 2
    • infliximab cyclosporin efficacy and pharmacotherapy nutrition support: 1, 2
    • infliximab cyclosporin efficacy and pouch anal anastomosis: 1, 2
    • infliximab cyclosporin efficacy and short term: 1, 2